1
|
Saha S, Maity S, Mazumdar R, Samanta B, Ghosh R, Guha AK, Mondal B. Sixth Ligand Induced HNO/NO - Release by a Five-Coordinated Cobalt(II) Nitrosyl Complex Having a {CoNO} 8 Configuration. Inorg Chem 2023; 62:17074-17082. [PMID: 37811901 DOI: 10.1021/acs.inorgchem.3c01124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/10/2023]
Abstract
Nitroxyl (HNO) and nitroxide (NO-) anion, the one-electron-reduced form of nitric oxide (NO), have been shown to have distinct advantages over NO from pharmacological and therapeutic points of view. However, the role of nitroxyl in chemical biology has not yet been studied as extensively as that of NO. Consequently, only a few examples of HNO donors such as Angeli's salt, Piloty's acid, or acyl- and acyloxynitroso derivatives are known. However, the intrinsic limitations of all of these hinder their widespread utility. Metal nitrosyl complexes, although few examples, could serve as an efficient HNO donor. Here, a cobalt nitrosyl complex of the {CoNO}8 (1) configuration has been reported. This complex in the presence of a sixth ligand [BF4-, DTC- (diethyldithiocarbamate anion), or imidazole] releases/donates HNO/NO-. This has been confirmed using well-known HNO/NO- acceptors like [Fe(TPP)Cl] and [Fe(DTC)3]. The HNO release has been authenticated further by the detection and estimation of N2O using gas chromatography-mass spectroscopy as well as its reaction with PPh3.
Collapse
Affiliation(s)
- Shankhadeep Saha
- Department of Chemistry, Indian Institute of Technology (IIT) Guwahati, Guwahati, Assam 781039, India
| | - Sayani Maity
- Department of Chemistry, Indian Institute of Technology (IIT) Guwahati, Guwahati, Assam 781039, India
| | - Rakesh Mazumdar
- Department of Chemistry, Indian Institute of Technology (IIT) Guwahati, Guwahati, Assam 781039, India
| | - Bapan Samanta
- Department of Chemistry, Indian Institute of Technology (IIT) Guwahati, Guwahati, Assam 781039, India
| | - Riya Ghosh
- Department of Chemistry, Indian Institute of Technology (IIT) Guwahati, Guwahati, Assam 781039, India
| | - Ankur K Guha
- Advanced Computational Chemistry Center, Department of Chemistry, Cotton University, Guwahati, Assam781001, India
| | - Biplab Mondal
- Department of Chemistry, Indian Institute of Technology (IIT) Guwahati, Guwahati, Assam 781039, India
| |
Collapse
|
2
|
Reyes G, Ajdary R, Kankuri E, Kaschuk JJ, Kosonen H, Rojas OJ. Cellulose gelation in NaOH (aq) by CO 2 absorption: Effects of holding time and concentration on biomaterial development. Carbohydr Polym 2023; 302:120355. [PMID: 36604045 DOI: 10.1016/j.carbpol.2022.120355] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2022] [Revised: 11/11/2022] [Accepted: 11/12/2022] [Indexed: 11/24/2022]
Abstract
We address the limited solubility and early onset of gelation of aqueous sodium hydroxide to position it as a preferred green solvent for cellulose. For this purpose, we expand the concentration window (up to 12 wt%) by using a CO2-depleted air and adjusting the time the dope remains in the given atmosphere, before further processing (holding time) and regeneration conditions. Cellulose solutions are extruded following characteristic (rheology and extrusion) parameters to yield aligned filaments reaching tenacities up to 2.3 cN·dtex-1, similar to that of viscose. Further material demonstrations are achieved by direct ink writing of auxetic biomedical meshes (Poisson's ratio of -0.2, tensile strength of 115 kPa) and transparent films, which achieved a tensile strength and toughness of 47 MPa and 590 kJ·m-3, respectively. The results suggest an excellent outlook for cellulose transformation into bioproducts. Key to this development is the control of the gelation ensuing solution flow and polymer alignment, which depend on CO2 absorption, cellulose concentration, and holding time.
Collapse
Affiliation(s)
- Guillermo Reyes
- Biobased Colloids and Materials, Department of Bioproducts and Biosystems, School of Chemical Engineering, Aalto University, FI-00076 Espoo, Finland.
| | - Rubina Ajdary
- Biobased Colloids and Materials, Department of Bioproducts and Biosystems, School of Chemical Engineering, Aalto University, FI-00076 Espoo, Finland; Bioproducts Institute, Department of Chemical & Biological Engineering, Department of Chemistry and Department of Wood Science, 2360 East Mall, The University of British Columbia, Vancouver, BC V6T 1Z3, Canada
| | - Esko Kankuri
- Department of Pharmacology, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland.
| | - Joice J Kaschuk
- Biobased Colloids and Materials, Department of Bioproducts and Biosystems, School of Chemical Engineering, Aalto University, FI-00076 Espoo, Finland; Bioproducts Institute, Department of Chemical & Biological Engineering, Department of Chemistry and Department of Wood Science, 2360 East Mall, The University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
| | - Harri Kosonen
- UPM Pulp Research and Innovations, UPM, Paloasemantie 19, FI-53200 Lappeenranta, Finland.
| | - Orlando J Rojas
- Biobased Colloids and Materials, Department of Bioproducts and Biosystems, School of Chemical Engineering, Aalto University, FI-00076 Espoo, Finland; Bioproducts Institute, Department of Chemical & Biological Engineering, Department of Chemistry and Department of Wood Science, 2360 East Mall, The University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
| |
Collapse
|
3
|
Ajdary R, Abidnejad R, Lehtonen J, Kuula J, Raussi-Lehto E, Kankuri E, Tardy B, Rojas OJ. Bacterial nanocellulose enables auxetic supporting implants. Carbohydr Polym 2022; 284:119198. [DOI: 10.1016/j.carbpol.2022.119198] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2021] [Revised: 01/26/2022] [Accepted: 01/27/2022] [Indexed: 01/08/2023]
|
4
|
Ajdary R, Reyes G, Kuula J, Raussi-Lehto E, Mikkola TS, Kankuri E, Rojas OJ. Direct Ink Writing of Biocompatible Nanocellulose and Chitosan Hydrogels for Implant Mesh Matrices. ACS POLYMERS AU 2022; 2:97-107. [PMID: 35445214 PMCID: PMC9011395 DOI: 10.1021/acspolymersau.1c00045] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/14/2021] [Revised: 11/23/2021] [Accepted: 11/29/2021] [Indexed: 01/28/2023]
Abstract
Direct ink writing via single or multihead extrusion is used to synthesize layer-by-layer (LbL) meshes comprising renewable polysaccharides. The best mechanical performance (683 ± 63 MPa modulus and 2.5 ± 0.4 MPa tensile strength) is observed for 3D printed structures with full infill density, given the role of electrostatic complexation between the oppositely charged components (chitosan and cellulose nanofibrils). The LbL structures develop an unexpectedly high wet stability that undergoes gradual weight loss at neutral and slightly acidic pH. The excellent biocompatibility and noncytotoxicity toward human monocyte/macrophages and controllable shrinkage upon solvent exchange make the cellular meshes appropriate for use as biomedical implants.
Collapse
Affiliation(s)
- Rubina Ajdary
- Department of Bioproducts and Biosystems, School of Chemical Engineering, Aalto University, PO Box 16300, FI-00076 Aalto, Espoo, Finland.,Bioproducts Institute, Department of Chemical & Biological Engineering, Department of Chemistry and Department of Wood Science, 2360 East Mall, The University of British Columbia, Vancouver, BC V6T 1Z3, Canada
| | - Guillermo Reyes
- Department of Bioproducts and Biosystems, School of Chemical Engineering, Aalto University, PO Box 16300, FI-00076 Aalto, Espoo, Finland
| | - Jani Kuula
- Department of Neuroscience and Biomedical Engineering, School of Science, Aalto University, PO Box 16300, FI-00076 Aalto, Espoo, Finland
| | - Eija Raussi-Lehto
- Department of Neuroscience and Biomedical Engineering, School of Science, Aalto University, PO Box 16300, FI-00076 Aalto, Espoo, Finland.,R&D Development Services, Metropolia University of Applied Sciences, PL 4000, FI-00079, Metropolia, Helsinki, Finland
| | - Tomi S Mikkola
- Department of Obstetrics and Gynecology, University of Helsinki, and Helsinki University Hospital, 00290 Helsinki, Finland
| | - Esko Kankuri
- Department of Pharmacology, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland
| | - Orlando J Rojas
- Department of Bioproducts and Biosystems, School of Chemical Engineering, Aalto University, PO Box 16300, FI-00076 Aalto, Espoo, Finland.,Bioproducts Institute, Department of Chemical & Biological Engineering, Department of Chemistry and Department of Wood Science, 2360 East Mall, The University of British Columbia, Vancouver, BC V6T 1Z3, Canada
| |
Collapse
|
5
|
Amarakoon TN, Ke N, Aspinwall CA, Miranda KM. Quantification of intracellular HNO delivery with capillary zone electrophoresis. Nitric Oxide 2022; 118:49-58. [PMID: 34715361 PMCID: PMC8758193 DOI: 10.1016/j.niox.2021.10.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2021] [Revised: 10/20/2021] [Accepted: 10/21/2021] [Indexed: 01/03/2023]
Abstract
Redox signaling, wherein reactive and diffusible small molecules are channeled into specific messenger functions, is a critical component of signal transduction. A central principle of redox signaling is that the redox modulators are produced in a highly controlled fashion to specifically modify biotargets. Thiols serve as primary mediators of redox signaling as a function of the rich variety of adducts, which allows initiation of distinct cellular effects. Coupling the inherent reactivity of thiols with highly sensitive and selective chemical analysis protocols can facilitate identification of redox signaling agents, both in solution and in cultured cells. Here, we describe use of capillary zone electrophoresis to both identify and quantify sulfinamides, which are specific markers of the reaction of thiols with nitroxyl (HNO), a putative biologically relevant reactive nitrogen species.
Collapse
Affiliation(s)
- Thilini N Amarakoon
- Department of Chemistry and Biochemistry, University of Arizona, Tucson, AZ, 85721, USA
| | - Neng Ke
- Department of Chemistry and Biochemistry, University of Arizona, Tucson, AZ, 85721, USA
| | - Craig A Aspinwall
- Department of Chemistry and Biochemistry, University of Arizona, Tucson, AZ, 85721, USA; BIO5 Institute, University of Arizona, Tucson, AZ, 85721, USA; Department of Biomedical Engineering, University of Arizona, Tucson, AZ, 85721, USA
| | - Katrina M Miranda
- Department of Chemistry and Biochemistry, University of Arizona, Tucson, AZ, 85721, USA; BIO5 Institute, University of Arizona, Tucson, AZ, 85721, USA.
| |
Collapse
|
6
|
Updating NO •/HNO interconversion under physiological conditions: A biological implication overview. J Inorg Biochem 2020; 216:111333. [PMID: 33385637 DOI: 10.1016/j.jinorgbio.2020.111333] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2020] [Revised: 11/13/2020] [Accepted: 12/05/2020] [Indexed: 12/12/2022]
Abstract
Azanone (HNO/NO-), also called nitroxyl, is a highly reactive compound whose biological role is still a matter of debate. A key issue that remains to be clarified regarding HNO and its biological activity is that of its endogenous formation. Given the overlap of the molecular targets and reactivity of nitric oxide (NO•) and HNO, its chemical biology was perceived to be similar to that of NO• as a biological signaling agent. However, despite their closely related reactivity, NO• and HNO's biochemical pathways are quite different. Moreover, the reduction of nitric oxide to azanone is possible but necessarily coupled to other reactions, which drive the reaction forward, overcoming the unfavorable thermodynamic barrier. The mechanism of this NO•/HNO interplay and its downstream effects in different contexts were studied recently, showing that more than fifteen moderate reducing agents react with NO• producing HNO. Particularly, it is known that the reaction between nitric oxide and hydrogen sulfide (H2S) produces HNO. However, this rate constant was not reported yet. In this work, firstly the NO•/H2S effective rate constant was measured as a function of the pH. Then, the implications of these chemical (non-enzymatic), biologically compatible, routes to endogenous HNO formation was discussed. There is no doubt that HNO could be (is?) a new endogenously produced messenger that mediates specific physiological responses, many of which were attributed yet to direct NO• effects.
Collapse
|
7
|
Alday J, Mazzeo A, Suarez S. Selective detection of gasotransmitters using fluorescent probes based on transition metal complexes. Inorganica Chim Acta 2020. [DOI: 10.1016/j.ica.2020.119696] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
|
8
|
Regulation of the Proteolytic Activity of Cysteine Cathepsins by Oxidants. Int J Mol Sci 2020; 21:ijms21061944. [PMID: 32178437 PMCID: PMC7139492 DOI: 10.3390/ijms21061944] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2020] [Revised: 03/10/2020] [Accepted: 03/10/2020] [Indexed: 12/21/2022] Open
Abstract
Besides their primary involvement in the recycling and degradation of proteins in endo-lysosomal compartments and also in specialized biological functions, cysteine cathepsins are pivotal proteolytic contributors of various deleterious diseases. While the molecular mechanisms of regulation via their natural inhibitors have been exhaustively studied, less is currently known about how their enzymatic activity is modulated during the redox imbalance associated with oxidative stress and their exposure resistance to oxidants. More specifically, there is only patchy information on the regulation of lung cysteine cathepsins, while the respiratory system is directly exposed to countless exogenous oxidants contained in dust, tobacco, combustion fumes, and industrial or domestic particles. Papain-like enzymes (clan CA, family C1, subfamily C1A) encompass a conserved catalytic thiolate-imidazolium pair (Cys25-His159) in their active site. Although the sulfhydryl group (with a low acidic pKa) is a potent nucleophile highly susceptible to chemical modifications, some cysteine cathepsins reveal an unanticipated resistance to oxidative stress. Besides an introductory chapter and peculiar attention to lung cysteine cathepsins, the purpose of this review is to afford a concise update of the current knowledge on molecular mechanisms associated with the regulation of cysteine cathepsins by redox balance and by oxidants (e.g., Michael acceptors, reactive oxygen, and nitrogen species).
Collapse
|
9
|
Sun HJ, Lee WT, Leng B, Wu ZY, Yang Y, Bian JS. Nitroxyl as a Potential Theranostic in the Cancer Arena. Antioxid Redox Signal 2020; 32:331-349. [PMID: 31617376 DOI: 10.1089/ars.2019.7904] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Significance: As one-electron reduced molecule of nitric oxide (NO), nitroxyl (HNO) has gained enormous attention because of its novel physiological or pharmacological properties, ranging from cardiovascular protective actions to antitumoricidal effects. Recent Advances: HNO is emerging as a new entity with therapeutic advantages over its redox sibling, NO. The interests in the chemical, pharmacological, and biological characteristics of HNO have broadened our current understanding of its role in physiology and pathophysiology. Critical Issues: In particular, the experimental evidence suggests the therapeutic potential of HNO in tumor pharmacology, such as neuroblastoma, gastrointestinal tumor, ovarian, lung, and breast cancers. Indeed, HNO donors have been demonstrated to attenuate tumor proliferation and angiogenesis. Future Directions: In this review, the generation and detection of HNO are outlined, and the roles of HNO in cancer progression are further discussed. We anticipate that the completion of this review might give novel insights into the roles of HNO in cancer pharmacology and open up a novel field of cancer therapy based on HNO.
Collapse
Affiliation(s)
- Hai-Jian Sun
- Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
| | - Wei-Thye Lee
- Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
| | - Bin Leng
- Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
| | - Zhi-Yuan Wu
- Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
| | - Yong Yang
- State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, Center for New Drug Safety Evaluation and Research, China Pharmaceutical University, Nanjing, China
| | - Jin-Song Bian
- Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.,National University of Singapore (Suzhou) Research Institute, Suzhou, China
| |
Collapse
|
10
|
Li H, Yao Q, Xu F, Xu N, Ma X, Fan J, Long S, Du J, Wang J, Peng X. Recognition of Exogenous and Endogenous Nitroxyl in Living Cells via a Two-Photon Fluorescent Probe. Anal Chem 2018. [DOI: 10.1021/acs.analchem.7b05172] [Citation(s) in RCA: 36] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
|
11
|
Petkowski JJ, Bains W, Seager S. Natural Products Containing a Nitrogen-Sulfur Bond. JOURNAL OF NATURAL PRODUCTS 2018; 81:423-446. [PMID: 29364663 DOI: 10.1021/acs.jnatprod.7b00921] [Citation(s) in RCA: 93] [Impact Index Per Article: 15.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Only about 100 natural products are known to contain a nitrogen-sulfur (N-S) bond. This review thoroughly categorizes N-S bond-containing compounds by structural class. Information on biological source, biological activity, and biosynthesis is included, if known. We also review the role of N-S bond functional groups as post-translational modifications of amino acids in proteins and peptides, emphasizing their role in the metabolism of the cell.
Collapse
Affiliation(s)
- Janusz J Petkowski
- Department of Earth, Atmospheric, and Planetary Sciences, Massachusetts Institute of Technology , 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States
| | - William Bains
- Rufus Scientific , 37 The Moor, Melbourn, Royston, Herts SG8 6ED, U.K
| | - Sara Seager
- Department of Earth, Atmospheric, and Planetary Sciences, Massachusetts Institute of Technology , 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States
- Department of Physics, Massachusetts Institute of Technology , 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States
| |
Collapse
|
12
|
Ren M, Deng B, Zhou K, Wang JY, Kong X, Lin W. A targetable fluorescent probe for imaging exogenous and intracellularly formed nitroxyl in mitochondria in living cells. J Mater Chem B 2017; 5:1954-1961. [DOI: 10.1039/c6tb03388a] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
We have developed a new mitochondrial-targeted turn-on fluorescent HNO probe (Mito-HNO). Fluorescence imaging shows that Mito-HNO is suitable for ratiometric visualization of HNO within mitochondria in living cells.
Collapse
Affiliation(s)
- Mingguang Ren
- Institute of Fluorescent Probes for Biological Imaging
- School of Materials Science and Engineering
- School of Chemistry and Chemical Engineering
- University of Jinan
- Jinan
| | - Beibei Deng
- Institute of Fluorescent Probes for Biological Imaging
- School of Materials Science and Engineering
- School of Chemistry and Chemical Engineering
- University of Jinan
- Jinan
| | - Kai Zhou
- Institute of Fluorescent Probes for Biological Imaging
- School of Materials Science and Engineering
- School of Chemistry and Chemical Engineering
- University of Jinan
- Jinan
| | - Jian-Yong Wang
- Institute of Fluorescent Probes for Biological Imaging
- School of Materials Science and Engineering
- School of Chemistry and Chemical Engineering
- University of Jinan
- Jinan
| | - Xiuqi Kong
- Institute of Fluorescent Probes for Biological Imaging
- School of Materials Science and Engineering
- School of Chemistry and Chemical Engineering
- University of Jinan
- Jinan
| | - Weiying Lin
- Institute of Fluorescent Probes for Biological Imaging
- School of Materials Science and Engineering
- School of Chemistry and Chemical Engineering
- University of Jinan
- Jinan
| |
Collapse
|
13
|
Bianco CL, Toscano JP, Bartberger MD, Fukuto JM. The chemical biology of HNO signaling. Arch Biochem Biophys 2016; 617:129-136. [PMID: 27555493 DOI: 10.1016/j.abb.2016.08.014] [Citation(s) in RCA: 35] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2016] [Revised: 08/15/2016] [Accepted: 08/18/2016] [Indexed: 12/15/2022]
Abstract
Nitroxyl (HNO) is a simple molecule with significant potential as a pharmacological agent. For example, its use in the possible treatment of heart failure has received recent attention due to its unique therapeutic properties. Recent progress has been made on the elucidation of the mechanisms associated with its biological signaling. Importantly, the biochemical mechanisms described for HNO bioactivity are consistent with its unique and novel chemical properties/reactivity. To date, much of the biology of HNO can be associated with interactions and modification of important regulatory thiol proteins. Herein will be provided a description of HNO chemistry and how this chemistry translates to some of its reported biological effects.
Collapse
Affiliation(s)
| | - John P Toscano
- Department of Chemistry, Johns Hopkins University, Baltimore, MD 21218, USA
| | - Michael D Bartberger
- Department of Therapeutic Discovery, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA
| | - Jon M Fukuto
- Department of Chemistry, Sonoma State University, Rohnert Park, CA 94928, USA.
| |
Collapse
|
14
|
Nitroxyl (HNO): A Reduced Form of Nitric Oxide with Distinct Chemical, Pharmacological, and Therapeutic Properties. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY 2015; 2016:4867124. [PMID: 26770654 PMCID: PMC4685437 DOI: 10.1155/2016/4867124] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/05/2015] [Revised: 08/14/2015] [Accepted: 09/01/2015] [Indexed: 01/18/2023]
Abstract
Nitroxyl (HNO), the one-electron reduced form of nitric oxide (NO), shows a distinct chemical and biological profile from that of NO. HNO is currently being viewed as a vasodilator and positive inotropic agent that can be used as a potential treatment for heart failure. The ability of HNO to react with thiols and thiol containing proteins is largely used to explain the possible biological actions of HNO. Herein, we summarize different aspects related to HNO including HNO donors, chemistry, biology, and methods used for its detection.
Collapse
|
15
|
Siltanen A, Nuutila K, Imanishi Y, Uenaka H, Mäkelä J, Pätilä T, Vento A, Miyagawa S, Sawa Y, Harjula A, Kankuri E. The Paracrine Effect of Skeletal Myoblasts Is Cardioprotective Against Oxidative Stress and Involves EGFR-ErbB4 Signaling, Cystathionase, and the Unfolded Protein Response. Cell Transplant 2015; 25:55-69. [PMID: 26021843 DOI: 10.3727/096368915x688254] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
Therapeutic effects of skeletal myoblast transplantation into the myocardium are mediated via paracrine factors. We investigated the ability of myoblast-derived soluble mediators to protect cardiomyocytes from oxidative stress. Fetal rat cardiac cells were treated with conditioned medium from cultures of myoblasts or cardiac fibroblasts, and oxidative stress was induced with H2O2. Myoblast-derived factors effectively prevented oxidative stress-induced cardiac cell death and loss of mitochondrial membrane potential. This protective effect was mediated via epidermal growth factor (EGF) receptor and c-Met signaling, and mimicked by neuregulin 1 but not EGF. Microarray analysis of cardiac cells treated with myoblast versus cardiac fibroblast-derived mediators revealed differential regulation of genes associated with antioxidative effects: cystathionine-γ-lyase (cst), xanthine oxidase, and thioredoxin-interacting protein as well as tribbles homolog 3 (trib3). Cardiac cell pretreatment with tunicamycin, an inducer of trib3, also protected them against H2O2-induced cell death. Epicardial transplantation of myoblast sheets in a rat model of acute myocardial infarction was used to evaluate the expression of CST and trib3 as markers of myoblasts' paracrine effect in vivo. Myoblast sheets induced expression of the CST as well as trib3 in infarcted myocardium. CST localized around blood vessels, suggesting smooth muscle cell localization. Our results provide a deeper molecular insight into the therapeutic mechanisms of myoblast-derived paracrine signaling in cardiac cells and suggest that myoblast transplantation therapy may prevent oxidative stress-induced cardiac deterioration and progression of heart failure.
Collapse
|
16
|
Johnson GM, Chozinski TJ, Gallagher ES, Aspinwall CA, Miranda KM. Glutathione sulfinamide serves as a selective, endogenous biomarker for nitroxyl after exposure to therapeutic levels of donors. Free Radic Biol Med 2014; 76:299-307. [PMID: 25064322 PMCID: PMC4254043 DOI: 10.1016/j.freeradbiomed.2014.07.022] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/27/2014] [Revised: 07/15/2014] [Accepted: 07/16/2014] [Indexed: 11/21/2022]
Abstract
Nitroxyl (HNO) donors exhibit promising pharmacological characteristics for treatment of cardiovascular disorders, cancer, and alcoholism. However, whether HNO also serves as an endogenous signaling agent is currently unknown, largely because of the inability to selectively and sensitively detect HNO in a cellular environment. Although a number of methods to detect HNO have been developed recently, sensitivity and selectivity against other nitrogen oxides or biological reductants remain problematic. To improve selectivity, the electrophilic nature of HNO has been harnessed to generate modifications of thiols and phosphines that are unique to HNO, especially compared to nitric oxide (NO). Given high bioavailability, glutathione (GSH) is expected to be a major target of HNO. As a result, the putative selective product glutathione sulfinamide (GS(O)NH2) may serve as a high-yield biomarker of HNO production. In this work, the formation of GS(O)NH2 after exposure to HNO donors was investigated. Fluorescent labeling followed by separation and detection using capillary zone electrophoresis with laser-induced fluorescence allowed quantitation of GS(O)NH2 with nanomolar sensitivity, even in the presence of GSH and derivatives. Formation of GS(O)NH2 was found to occur exclusively upon exposure of GSH to HNO donors, thus confirming selectivity. GS(O)NH2 was detected in the lysate of cells treated with low-micromolar concentrations of HNO donors, verifying that this species has sufficient stability to server as a biomarker of HNO. Additionally, the concentration-dependent formation of GS(O)NH2 in cells treated with an HNO donor suggests that the concentration of GS(O)NH2 can be correlated to intracellular levels of HNO.
Collapse
Affiliation(s)
- Gail M Johnson
- Department of Chemistry and Biochemistry, University of Arizona, Tucson, AZ 85721, USA
| | - Tyler J Chozinski
- Department of Chemistry and Biochemistry, University of Arizona, Tucson, AZ 85721, USA
| | - Elyssia S Gallagher
- Department of Chemistry and Biochemistry, University of Arizona, Tucson, AZ 85721, USA
| | - Craig A Aspinwall
- Department of Chemistry and Biochemistry, University of Arizona, Tucson, AZ 85721, USA
| | - Katrina M Miranda
- Department of Chemistry and Biochemistry, University of Arizona, Tucson, AZ 85721, USA.
| |
Collapse
|
17
|
Bharadwaj G, Benini PGZ, Basudhar D, Ramos-Colon CN, Johnson GM, Larriva MM, Keefer LK, Andrei D, Miranda KM. Analysis of the HNO and NO donating properties of alicyclic amine diazeniumdiolates. Nitric Oxide 2014; 42:70-8. [PMID: 25192820 DOI: 10.1016/j.niox.2014.08.013] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2014] [Revised: 08/28/2014] [Accepted: 08/31/2014] [Indexed: 11/17/2022]
Abstract
Nitroxyl (HNO) donors have been shown to elicit a variety of pharmacological responses, ranging from tumoricidal effects to treatment of heart failure. Isopropylamine-based diazeniumdiolates have been shown to produce HNO on decomposition under physiological conditions. Herein, we report the synthesis and HNO release profiles of primary alicyclic amine-based diazeniumdiolates. These compounds extend the range of known diazeniumdiolate-based HNO donors. Acetoxymethyl ester-protected diazeniumdiolates were also synthesized to improve purification and cellular uptake. The acetoxymethyl derivative of cyclopentylamine diazeniumdiolate not only showed higher cytotoxicity toward cancer cells as compared to the parent anion but was also effective in combination with tamoxifen for targeting estrogen receptor α-negative breast cancer cells.
Collapse
Affiliation(s)
- Gaurav Bharadwaj
- Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, USA
| | - Patricia G Z Benini
- Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, USA
| | - Debashree Basudhar
- Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, USA
| | - Cyf N Ramos-Colon
- Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, USA
| | - Gail M Johnson
- Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, USA
| | - Marti M Larriva
- Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, USA
| | - Larry K Keefer
- Chemical Biology Laboratory, National Cancer Institute at Frederick, Frederick, Maryland 21702, USA
| | - Daniela Andrei
- Chemical Biology Laboratory, National Cancer Institute at Frederick, Frederick, Maryland 21702, USA
| | - Katrina M Miranda
- Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, USA.
| |
Collapse
|
18
|
Affiliation(s)
- Gizem Keceli
- Department
of Chemistry, Johns Hopkins University, Baltimore, Maryland 21218, United States
| | - John P. Toscano
- Department
of Chemistry, Johns Hopkins University, Baltimore, Maryland 21218, United States
| |
Collapse
|
19
|
Keceli G, Moore CD, Labonte JW, Toscano JP. NMR detection and study of hydrolysis of HNO-derived sulfinamides. Biochemistry 2013; 52:7387-96. [PMID: 24073927 DOI: 10.1021/bi401110f] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Nitroxyl (HNO), a potential heart failure therapeutic, is known to post-translationally modify cysteine residues. Among reactive nitrogen oxide species, the modification of cysteine residues to sulfinamides [RS(O)NH2] is unique to HNO. We have applied (15)N-edited (1)H NMR techniques to detect the HNO-induced thiol to sulfinamide modification in several small organic molecules, peptides, and the cysteine protease, papain. Relevant reactions of sulfinamides involve reduction to free thiols in the presence of excess thiol and hydrolysis to form sulfinic acids [RS(O)OH]. We have investigated sulfinamide hydrolysis at physiological pH and temperature. Studies with papain and a related model peptide containing the active site thiol suggest that sulfinamide hydrolysis can be enhanced in a protein environment. These findings are also supported by modeling studies. In addition, analysis of peptide sulfinamides at various pH values suggests that hydrolysis becomes more facile under acidic conditions.
Collapse
Affiliation(s)
- Gizem Keceli
- Department of Chemistry, Johns Hopkins University , Baltimore, Maryland 21218, United States
| | | | | | | |
Collapse
|
20
|
Abstract
Sulfinamide [RS(O)NH(2)] formation is known to occur upon exposure of cysteine residues to nitroxyl (HNO), which has received recent attention as a potential heart failure therapeutic. Because this modification can alter protein structure and function, we have examined the reactivity of sulfinamides in several systems, including a small organic molecule, peptides, and a protein. Although it has generally been assumed that this thiol to sulfinamide modification is irreversible, we show that sulfinamides can be reduced back to the free thiol in the presence of excess thiol at physiological pH and temperature. We have examined this sulfinamide reduction both in peptides, where a cyclic intermediate analogous to that proposed for asparagine deamidation reactions potentially can contribute, and in a small organic molecule, where the mechanism is restricted to a direct thiolysis. These studies suggest that the contribution from the cyclic intermediate becomes more important in environments with lower dielectric constants. In addition, although sulfinic acid [RS(O)OH] formation is observed upon prolonged incubations in water, reduction of sulfinamides is found to dominate in the presence of thiols. Finally, studies with the cysteine protease, papain, suggest that the reduction of sulfinamide to the free thiol is viable in a protein environment.
Collapse
Affiliation(s)
- Gizem Keceli
- Department of Chemistry, Johns Hopkins University, Baltimore, MD 21218, USA
| | | |
Collapse
|
21
|
Doctorovich F, Bikiel D, Pellegrino J, Suárez SA, Larsen A, Martí MA. Nitroxyl (azanone) trapping by metalloporphyrins. Coord Chem Rev 2011. [DOI: 10.1016/j.ccr.2011.04.012] [Citation(s) in RCA: 76] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
22
|
Abstract
Due to recent discoveries of important and novel biological activity, nitroxyl (HNO) has become a molecule of significant interest. Although it has been used in the past as a treatment for alcoholism, it is currently being touted as a treatment for heart failure. It is becoming increasingly clear that many of the biological actions of HNO can be attributed to its ability to react with specific thiol- and, possibly, heme-proteins. Herein is discussed the chemistry of HNO with likely biological targets. A particular focus is given to targets associated with the pharmacological utility of HNO as a cardiovascular agent and for the treatment of alcoholism.
Collapse
Affiliation(s)
- Jon M Fukuto
- Department of Chemistry, Sonoma State University, Rohnert Park, California 94928, USA.
| | | |
Collapse
|
23
|
Choe CU, Lewerenz J, Gerloff C, Magnus T, Donzelli S. Nitroxyl in the central nervous system. Antioxid Redox Signal 2011; 14:1699-711. [PMID: 21235347 DOI: 10.1089/ars.2010.3852] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
Abstract
Nitroxyl (HNO) is the one-electron-reduced and protonated congener of nitric oxide (NO). Compared to NO, it is far more reactive with thiol groups either in proteins or in small antioxidant molecules either converting those into sulfinamides or inducing disulfide bond formation. HNO might mediate cytoprotective changes of protein function through thiol modifications. However, HNO is a strong oxidant that in vitro reacts with glutathione to form glutathione disulfide and glutathione sulfinamide. The resulting oxidative stress might aggravate tissue damage in inflammatory diseases. In this review, we will summarize the current knowledge of how exogenous HNO affects the central nervous system, especially nerve cells and glia in health and disease. Unlike most other organs, the brain is separated from the circulation by the blood-brain barrier, which limits access of many pharmacological compounds. Given that, we will review what is known about the ability of currently used HNO donors to cross the blood-brain barrier. Moreover, considering that the physiology and composition of the brain has unique properties, for example, expression of brain-specific enzymes like neuronal NO synthase, its high iron content, and increased energy metabolism, we will discuss possible sources of endogenous HNO in the brain.
Collapse
Affiliation(s)
- Chi-Un Choe
- Department of Neurology, University Hospital Hamburg-Eppendorf, Germany
| | | | | | | | | |
Collapse
|
24
|
Bakhmutova-Albert EV, Yao H, Denevan DE, Richardson DE. Kinetics and Mechanism of Peroxymonocarbonate Formation. Inorg Chem 2010; 49:11287-96. [DOI: 10.1021/ic1007389] [Citation(s) in RCA: 91] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
| | - Huirong Yao
- Center for Catalysis, Department of Chemistry, University of Florida, Gainesville, Florida 32611-7200, United States
| | - Daniel E. Denevan
- Center for Catalysis, Department of Chemistry, University of Florida, Gainesville, Florida 32611-7200, United States
| | - David E. Richardson
- Center for Catalysis, Department of Chemistry, University of Florida, Gainesville, Florida 32611-7200, United States
| |
Collapse
|
25
|
Sherman MP, Grither WR, McCulla RD. Computational Investigation of the Reaction Mechanisms of Nitroxyl and Thiols. J Org Chem 2010; 75:4014-24. [DOI: 10.1021/jo100172t] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Matthew P. Sherman
- Department of Chemistry, Saint Louis University, 3501 Laclede Avenue, Saint Louis, Missouri 63103
| | - Whitney R. Grither
- Department of Chemistry, Saint Louis University, 3501 Laclede Avenue, Saint Louis, Missouri 63103
| | - Ryan D. McCulla
- Department of Chemistry, Saint Louis University, 3501 Laclede Avenue, Saint Louis, Missouri 63103
| |
Collapse
|
26
|
Kitabayashi K, Siltanen A, Pätilä T, Mahar MAA, Tikkanen I, Koponen J, Ono M, Sawa Y, Kankuri E, Harjula A. Bcl-2 Expression Enhances Myoblast Sheet Transplantation Therapy for Acute Myocardial Infarction. Cell Transplant 2010; 19:573-88. [DOI: 10.3727/096368909x486048] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
Myoblast sheet transplantation is a promising novel treatment modality for heart failure after an ischemic insult. However, low supply of blood and nutrients may compromise sheet survival. The aim of this study was to investigate the effect of mitochondria-protective Bcl-2-modified myoblasts in cell sheet transplantation therapy. In the Bcl-2-expressing rat L6 myoblast sheets (L6-Bcl2), increased expression of myocyte markers and angiogenic mediators was evident compared to wild-type (L6-WT) sheets. The L6-Bcl2 sheets demonstrated significant resistance to apoptotic stimuli, and their differentiation capacity in vitro was increased. We evaluated the therapeutic effect of Bcl-2-modified myoblast sheets in a rat model of acute myocardial infarction (AMI). Sixty-four Wistar rats were divided into four groups. One group underwent AMI ( n = 22), another AMI and L6-WT sheet transplantation ( n = 17), and a third AMI and L6-Bcl2 sheet transplantation ( n = 20). Five rats underwent a sham operation. Echocardiography was performed after 3, 10, and 28 days. Samples for histological analysis were collected at the end of the study. After AMI, the Bcl-2-expressing sheets survived longer on the infarcted myocardium, and significantly improved cardiac function. L6-Bcl2 sheet transplantation reduced myocardial fibrosis and increased vascular density in infarct and border areas. Moreover, the number of c-kit-positive and proliferating cells in the myocardium was increased in the L6-Bcl2 group. In conclusion, Bcl-2 prolongs survival of myoblast sheets, increases production of proangiogenic paracrine mediators, and enhances the therapeutic efficacy of cell sheet transplantation.
Collapse
Affiliation(s)
- Katsukiyo Kitabayashi
- Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka, Japan
- Institute of Biomedicine, Pharmacology, University of Helsinki, Helsinki, Finland
- Department of Cardiothoracic Surgery, Helsinki University Meilahti Hospital, Helsinki, Finland
| | - Antti Siltanen
- Institute of Biomedicine, Pharmacology, University of Helsinki, Helsinki, Finland
| | - Tommi Pätilä
- Institute of Biomedicine, Pharmacology, University of Helsinki, Helsinki, Finland
- Department of Cardiothoracic Surgery, Helsinki University Meilahti Hospital, Helsinki, Finland
| | | | - Ilkka Tikkanen
- Minerva Foundation Institute for Medical Research, Helsinki, Finland
| | - Jonna Koponen
- A.I. Virtanen Institute for Molecular Sciences, Department of Biotechnology and Molecular Medicine, University of Kuopio, Kuopio, Finland
| | - Masamichi Ono
- Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka, Japan
| | - Yoshiki Sawa
- Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka, Japan
| | - Esko Kankuri
- Institute of Biomedicine, Pharmacology, University of Helsinki, Helsinki, Finland
- Department of Cardiothoracic Surgery, Helsinki University Meilahti Hospital, Helsinki, Finland
| | - Ari Harjula
- Institute of Biomedicine, Pharmacology, University of Helsinki, Helsinki, Finland
- Department of Cardiothoracic Surgery, Helsinki University Meilahti Hospital, Helsinki, Finland
| |
Collapse
|
27
|
Fukuto JM, Bianco CL, Chavez TA. Nitroxyl (HNO) signaling. Free Radic Biol Med 2009; 47:1318-24. [PMID: 19539748 DOI: 10.1016/j.freeradbiomed.2009.06.014] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/24/2009] [Revised: 06/10/2009] [Accepted: 06/11/2009] [Indexed: 11/16/2022]
Abstract
Nitroxyl (HNO) has become a nitrogen oxide of significant interest due to its reported biological activity. The actions of HNO in the cardiovascular system appear to make it a good candidate for therapeutic applications for cardiovascular disorders and other potentially important effects have been noted as well. Although the chemistry associated with this activity has not been firmly established, the propensity for HNO to react with thiols and metals are likely mechanisms. Herein, are described the biological activity of HNO and some of the chemistry of HNO that may be responsible for its biological effects.
Collapse
Affiliation(s)
- Jon M Fukuto
- Department of Chemistry, Sonoma State University, Rohnert Park, CA 94928, USA.
| | | | | |
Collapse
|
28
|
Switzer CH, Flores-Santana W, Mancardi D, Donzelli S, Basudhar D, Ridnour LA, Miranda KM, Fukuto JM, Paolocci N, Wink DA. The emergence of nitroxyl (HNO) as a pharmacological agent. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS 2009; 1787:835-40. [PMID: 19426703 DOI: 10.1016/j.bbabio.2009.04.015] [Citation(s) in RCA: 101] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/30/2008] [Revised: 04/28/2009] [Accepted: 04/29/2009] [Indexed: 11/15/2022]
Abstract
Once a virtually unknown nitrogen oxide, nitroxyl (HNO) has emerged as a potential pharmacological agent. Recent advances in the understanding of the chemistry of HNO has led to the an understanding of HNO biochemistry which is vastly different from the known chemistry and biochemistry of nitric oxide (NO), the one-electron oxidation product of HNO. The cardiovascular roles of NO have been extensively studied, as NO is a key modulator of vascular tone and is involved in a number of vascular related pathologies. HNO displays unique cardiovascular properties and has been shown to have positive lusitropic and ionotropic effects in failing hearts without a chronotropic effect. Additionally, HNO causes a release of CGRP and modulates calcium channels such as ryanodine receptors. HNO has shown beneficial effects in ischemia reperfusion injury, as HNO treatment before ischemia-reperfusion reduces infarct size. In addition to the cardiovascular effects observed, HNO has shown initial promise in the realm of cancer therapy. HNO has been demonstrated to inhibit GAPDH, a key glycolytic enzyme. Due to the Warburg effect, inhibiting glycolysis is an attractive target for inhibiting tumor proliferation. Indeed, HNO has recently been shown to inhibit tumor proliferation in mouse xenografts. Additionally, HNO inhibits tumor angiogenesis and induces cancer cell apoptosis. The effects seen with HNO donors are quite different from NO donors and in some cases are opposite. The chemical nature of HNO explains how HNO and NO, although closely chemically related, act so differently in biochemical systems. This also gives insight into the potential molecular motifs that may be reactive towards HNO and opens up a novel field of pharmacological development.
Collapse
Affiliation(s)
- Christopher H Switzer
- Radiation Biology Branch, National Cancer Institute, National Institutes of Health, Building 10, Room B3-B35, Bethesda, MD 20892, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Väänänen AJ, Salmenperä P, Hukkanen M, Miranda KM, Harjula A, Rauhala P, Kankuri E. Persistent susceptibility of cathepsin B to irreversible inhibition by nitroxyl (HNO) in the presence of endogenous nitric oxide. Free Radic Biol Med 2008; 45:749-55. [PMID: 18572022 DOI: 10.1016/j.freeradbiomed.2008.05.025] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/19/2007] [Revised: 04/02/2008] [Accepted: 05/21/2008] [Indexed: 10/22/2022]
Abstract
Nitrosation of enzyme regulatory cysteines is one of the key posttranslational modification mechanisms of enzyme function. Frequently such modifications are readily reversible; however, cysteine proteases, such as cathepsin B, have been shown to be covalently and permanently inactivated by nitroxyl (HNO), the one-electron reduction product of NO. Owing to the high reactivity of HNO with NO, endogenous NO production could provide direct protection for the less reactive protein cysteines by scavenging HNO. Additionally, endogenous cellular production of NO could rescue enzyme function by protective nitrosation of cysteines prior to exposure to HNO. Thus, we studied the effect of endogenous NO production, induced by LPS or IFN-gamma, on inhibition of cysteine protease cathepsin B in RAW macrophages. Both LPS and IFN-gamma induce iNOS with generation of nitrate up to 9 muM in the media after a 24-h stimulation, while native RAW 264.7 macrophages neither express iNOS nor generate nitrate. After the 24-h stimulation, the HNO-releasing Angeli's salt (0-316 microM) caused dose-dependent and DTT-irreversible loss of cathepsin B activity, and induction of iNOS activity did not protect the enzyme. The lack of protection was also verified in an in vitro setup, where papain, a close structural analogue of cathepsin B, was inhibited by Angeli's salt (2.7 microM) in the presence of the NO donor DEA/NO (0-316 microM). This clearly showed that a high molar excess of DEA/NO (EC(50) 406 microM) is needed to protect papain from the DTT-irreversible covalent modification by HNO. Our results provide first evidence on a cellular level for the remarkably high sensitivity of active-site cysteines in cysteine proteases for modification by HNO.
Collapse
Affiliation(s)
- Antti J Väänänen
- Department of Pharmacology, Institute of Biomedicine, Biomedicum Helsinki, P.O. Box 63, FIN-00014 University of Helsinki, Finland
| | | | | | | | | | | | | |
Collapse
|
30
|
Hervé-Grépinet V, Veillard F, Godat E, Heuzé-Vourc'h N, Lecaille F, Lalmanach G. Extracellular catalase activity protects cysteine cathepsins from inactivation by hydrogen peroxide. FEBS Lett 2008; 582:1307-12. [PMID: 18343226 DOI: 10.1016/j.febslet.2008.03.007] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2007] [Revised: 02/08/2008] [Accepted: 03/05/2008] [Indexed: 11/15/2022]
Abstract
The resistance of secreted cysteine cathepsins to peroxide inactivation was evaluated using as model THP-1 cells. Differentiated cells released mostly cathepsin B, but also cathepsins H, K, and L, with a maximum of endopeptidase activity at day 6. Addition of non-cytotoxic concentrations of H(2)O(2) did not affect mRNA expression levels and activity of cathepsins, while the catalase activity remained also unchanged, consistently with RT-PCR analysis. Conversely inhibition of extracellular catalase led to a striking inactivation of secreted cysteine cathepsins by H(2)O(2). This report suggests that catalase may participate in the protection of extracellular cysteine proteases against peroxidation.
Collapse
Affiliation(s)
- Virginie Hervé-Grépinet
- INSERM U 618, Protéases et Vectorisation Pulmonaires, Equipe Protéases et Pathologies Pulmonaires, Tours F-37000, France
| | | | | | | | | | | |
Collapse
|
31
|
Norris AJ, Sartippour MR, Lu M, Park T, Rao JY, Jackson MI, Fukuto JM, Brooks MN. Nitroxyl inhibits breast tumor growth and angiogenesis. Int J Cancer 2008; 122:1905-10. [PMID: 18076071 DOI: 10.1002/ijc.23305] [Citation(s) in RCA: 71] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
Nitroxyl (HNO) can inhibit the glycolytic enzyme glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Because of the importance of glycolysis in many malignant cells, we thus propose that HNO can adversely affect tumor growth. This hypothesis was tested using in vitro and in vivo models of breast cancer. We report here for the first time that HNO suppresses the proliferation of both estrogen receptor (ER)-positive and ER-negative human breast cancer cell lines, in a dose dependent manner. Mice treated with HNO either injected into the tumor itself or via the intraperitoneal approach had smaller xenograft tumor size. In addition to significantly decreased blood vessel density in the HNO-treated tumors, we observed lower levels of circulating serum vascular endothelial growth factor (VEGF). Accordingly, there was a decrease in total HIF-1alpha (hypoxia-inducible factor) protein in HNO-treated tumor cells. Further studies showed inhibition of GAPDH activity in HNO-treated human breast cancer cell lines and in HNO-treated tumor tissue derived from xenografts. One explanation for the multiplicity of actions observed after HNO treatment could be the effect from the initial inhibition of GAPDH, providing a potential therapeutic avenue based upon blocking glycolysis resulting in decreased HIF-1alpha, thus leading to angiogenesis inhibition. Therefore, HNO appears to act via mechanism(s) different from those of existing breast cancer drugs, making it a potential candidate to overcome known and emerging drug resistance pathways.
Collapse
Affiliation(s)
- Andrew J Norris
- Surgical Oncology, UCLA School of Medicine, Los Angeles, CA 90095, USA
| | | | | | | | | | | | | | | |
Collapse
|
32
|
Lopez BE, Wink DA, Fukuto JM. The inhibition of glyceraldehyde-3-phosphate dehydrogenase by nitroxyl (HNO). Arch Biochem Biophys 2007; 465:430-6. [PMID: 17678614 DOI: 10.1016/j.abb.2007.06.017] [Citation(s) in RCA: 50] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2007] [Revised: 06/11/2007] [Accepted: 06/25/2007] [Indexed: 11/21/2022]
Abstract
Nitroxyl (HNO) has received recent and significant interest due to its novel and potentially important pharmacology. However, the chemical/biochemical mechanism(s) responsible for its biological activity remain to be established. Some of the most important biological targets for HNO are thiols and thiol proteins. Consistent with this, it was recently reported that HNO inhibits the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a protein with a catalytically important cysteine thiol at its active site. Interestingly, it was reported that intracellular GAPDH inhibition occurred without significantly altering the cellular thiol redox status of glutathione. Herein, the nature of this reaction specificity was examined. HNO is found to irreversibly inhibit GAPDH in a manner that can be protected against by one of its substrates, glyceraldehyde-3-phosphate (G-3-P). These results are consistent with the idea that HNO has the ability to react with and oxidize a variety of intracellular thiols and the ease or facility of cellular re-reduction of the thiol targets can determine the target specificity.
Collapse
Affiliation(s)
- Brenda E Lopez
- Department of Pharmacology, UCLA School of Medicine, Center for the Health Sciences, Los Angeles, CA 90095-1735, USA
| | | | | |
Collapse
|
33
|
Paolocci N, Jackson MI, Lopez BE, Tocchetti CG, Wink DA, Hobbs A, Fukuto JM. The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO. Pharmacol Ther 2007; 113:442-58. [PMID: 17222913 PMCID: PMC3501193 DOI: 10.1016/j.pharmthera.2006.11.002] [Citation(s) in RCA: 198] [Impact Index Per Article: 11.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2006] [Accepted: 11/10/2006] [Indexed: 11/29/2022]
Abstract
Nitroxyl (HNO), the 1-electron reduced and protonated congener of nitric oxide (NO), has received recent attention as a potential pharmacological agent for the treatment of heart failure and as a preconditioning agent for the mitigation of ischemia-reperfusion injury. Interest in the pharmacology and biology of HNO has prompted examination, or in some instances reexamination, of many of its chemical properties. Such studies have provided insight into the chemical basis for the biological effects of HNO, although the biochemical mechanisms for many of these effects remain to be established. In this review, a brief description of the biologically relevant chemistry of HNO is given, followed by a more detailed discussion of the pharmacology and potential toxicology of HNO.
Collapse
Affiliation(s)
- Nazareno Paolocci
- Division of Cardiology, Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD 21287
| | - Matthew I. Jackson
- Interdepartmental Program in Molecular Toxicology, UCLA School of Public Health, Los Angeles, CA, 90095-1772
| | - Brenda E. Lopez
- Department of Pharmacology, UCLA School of Medicine, Center for the Health Sciences, Los Angeles, CA 90095-1735
| | - Carlo G. Tocchetti
- Division of Cardiology, Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD 21287
| | - David A. Wink
- Radiation Biology Branch, National Cancer Institute Bethesda, MD 20892
| | - Adrian Hobbs
- Wolfson Institute for Biomedical Research, University College, Cruciform Building, Gower Street, London, WC1E 6AE, UK
| | - Jon M. Fukuto
- Interdepartmental Program in Molecular Toxicology, UCLA School of Public Health, Los Angeles, CA, 90095-1772
- Department of Pharmacology, UCLA School of Medicine, Center for the Health Sciences, Los Angeles, CA 90095-1735
| |
Collapse
|